| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | Chief Legal & Compliance Offic | Restricted Stock Units | 20K | $33.5K | $1.68 | Sep 30, 2024 | Direct |
| Syros Pharmaceuticals, Inc. | Chief Legal & Compliance Offic | Common Stock | 0 | $0 | $0.22 | Nov 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | Nov 19, 2024 | 1 | -$10.3K | 4 | Nov 20, 2024 | Chief Legal & Compliance Offic |
| SYRS | Syros Pharmaceuticals, Inc. | Sep 30, 2024 | 3 | -$6.51K | 4 | Oct 2, 2024 | Chief Legal & Compliance Offic |
| SYRS | Syros Pharmaceuticals, Inc. | Mar 27, 2024 | 3 | -$39.4K | 4 | Apr 2, 2024 | Chief Legal & Compliance Offic |
| SYRS | Syros Pharmaceuticals, Inc. | Oct 11, 2023 | 3 | -$14.5K | 4 | Oct 20, 2023 | Chief Legal & Compliance Offic |
| SYRS | Syros Pharmaceuticals, Inc. | Sep 12, 2023 | 1 | $0 | 4 | Sep 14, 2023 | Chief Legal & Compliance Offic |
| SYRS | Syros Pharmaceuticals, Inc. | Oct 11, 2022 | 1 | $0 | 4 | Oct 13, 2022 | Chief Legal Officer |
| SYRS | Syros Pharmaceuticals, Inc. | Oct 11, 2022 | 0 | $0 | 3 | Oct 13, 2022 | Chief Legal Officer |